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Abstract 
 
Aim: To determine absolute and relative risks of all-cause and cardiovascular mortality 
among patients newly diagnosed with type 2 diabetes. Methods: In an observational cohort 
study using record-linkage databases, based in Tayside, Scotland, UK, we identified newly 
diagnosed patients with type 2 diabetes in 1993-2004. We also identified a set of non-
diabetic comparators from lists of patients registered with General Practice, individually 
matched to the diabetic patients by sex, age and deprivation. We followed up patients for 
mortality and cardiovascular mortality over a 12 year period, and calculated hazard ratios 
(HRs) using Cox regression. Results: There were 10,532 patients with type 2 diabetes, and 
21,056 non-diabetic comparators. Diabetic patients in every age/sex group had higher 
absolute mortality rates. Even taking deprivation into account, the HR for mortality was 1.32 
(95% CI 1.25 to 1.40), decreasing to 1.15 (1.09 to 1.22) after adjusting for pre-existing 
cardiovascular disease. The HRs for cardiovascular mortality were higher, decreasing from 
1.51 (1.37 to 1.67) to 1.23 (1.11 to 1.36) after adjusting for pre-existing cardiovascular 
disease. The HRs decreased with increasing age at diagnosis, although the difference in 
absolute rate of mortality increased slightly with age. Increased mortality risks were only 
evident two years after diagnosis and increased thereafter. Conclusions: Patients with type 2 
diabetes have an increased risk of all-cause and cardiovascular mortality compared with non 
diabetic comparators, although this is not observable immediately after diagnosis.  Age at 
diagnosis and duration of the disease independently affect absolute and relative mortality 
risk. 
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Introduction 
Numerous studies have shown that type 2 diabetes reduces life expectancy 
1-4
 mainly due to 
an increased risk of cardiovascular mortality
3
.  Studies have suggested that patients with type 
2 diabetes may have up to a three-fold increase in mortality compared with people without 
diabetes
3,4
.  However, many studies that have investigated mortality have taken a cross-
sectional sample of patients with type 2 diabetes at one point in time and followed them up 
for mortality. The published risks then represent the mean increased risks across 
heterogeneous groups of patients with varying disease duration and age of diagnosis. The 
increased mortality risk among patients newly diagnosed with type 2 diabetes is not well 
documented. The few studies that have followed patients from diagnosis suggest that the 
relative risk of mortality associated with diabetes decreases with increasing age at diagnosis
5-
8
. 
 
Published literature on cardiovascular mortality in newly diagnosed patients with type 2 
diabetes is even less well documented, although a recent American study showed more than a 
two-fold increase in cardiovascular mortality in newly diagnosed older patients
9
. This study 
also found mortality risk to rise only two years after diagnosis and not increase thereafter, a 
finding that conflicts with studies that suggest that mortality rises with increasing duration of 
diabetes, independent of cardiovascular risk factors
10,11
.   
 
We used a diabetic clinical information system to follow up 10,532 patients newly diagnosed 
with type 2 diabetes in Tayside, Scotland and to evaluate the mortality risks associated with 
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type 2 diabetes.  We also investigated how age at diagnosis and disease duration affect all-
cause and cardiovascular mortality.  
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Methods  
 
This observational cohort study was carried out among the resident population of Tayside 
Health Board, Scotland (approx. 400,000 people). Data were provided by the Health 
Informatics Centre (HIC), University of Dundee, which has developed the record-linkage of 
multiple, routinely collected datasets to carry out anonymised health related research in 
Tayside. Electronic linkage is facilitated by the widespread use of a nine digit Community 
Health Identifier (CHI) that is assigned to all patients in Scotland registered with a General 
Practitioner.  Datasets used for this study include the SCI-DC diabetes clinical information 
system (formerly known as DARTS)
12
, computerised death certification records from the 
Registrar General with ICD9/ICD10-coded causes of death
13,14
, and Scottish Morbidity 
Records of inpatient hospital activity
15
. All HIC data are anonymised prior to analysis to 
maintain confidentiality and to conform to Data Protection legislation.   
 
SCI-DC/DARTS is a validated population-based diabetes clinical information system. The 
original DARTS database for Tayside has 95% sensitivity at identifying people with 
diabetes
12
. The register was used to identify all patients newly diagnosed with type 2 diabetes 
in Tayside between January 1993 and December 2004.  All patients who are diagnosed with 
diabetes aged 35 years or over are classified as having type 2 diabetes, as are those who are 
diagnosed when younger but with no requirement for insulin. However, because 
misclassification of diabetes type is common in younger age groups we restricted this study 
to patients over the age of 35 years.  We also excluded patients whose date of diagnosis was 
unknown or who left Tayside within the study period.  
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A non diabetic comparator cohort was generated at random from the community-based 
electronic lists of people registered with General Practitioners in Tayside. Two non-diabetic 
people were matched to every patient with type 2 diabetes for sex and age (within 1 year). 
Postal sectors in Scotland are assigned an area-based measure of material deprivation, known 
as the Carstairs score
16
. Comparators were therefore identified from the same postal sectors 
as the diabetic patients to take account of possible differences in deprivation related to 
geographical area. However, where this was not possible, a match was made on GP practice. 
The index date of a patient with diabetes was their date of diagnosis; also used as the index 
date for matched comparators (who had to be alive on this date).  Patients were followed up 
for a maximum of 12 years for mortality, to an end-date of 9
th
 February 2005 (the last date 
for which dates of death were available). The underlying cause of death was ascertained from 
death certificate records. 
 
Information on whether patients had been hospitalized with any ICD9/10 diagnosis code for 
cardiovascular disease at any time from 1980 onwards was obtained from the Scottish 
Morbidity Record 1 (SMR01) to identify those with pre-existing cardiovascular disease 
(ICD9 codes 410-414, 428-438, 518.4, 786.5 and corresponding ICD10 codes). SMR01 
holds information on all hospital admissions in Scotland from 1980.   
 
We obtained the numbers of deaths for diabetic patients and non-diabetic comparators, 
stratified by sex and age at diagnosis. Cardiovascular deaths were identified as those that had 
a cardiovascular code for the underlying cause of death on the death certificate (codes 
defined above). We calculated absolute rates of all-cause and cardiovascular mortality by 
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dividing the total numbers of deaths in each age/sex group by the total number of days follow 
up (to the end of the study or to a participant’s date of death). A Kaplan-Meier survival curve 
was constructed for diabetic and non-diabetic comparators and a Cox regression survival 
analysis was used to calculate unadjusted hazard ratios (HRs) for all-cause and 
cardiovascular mortality. Because not all patients were matched for postal sector, we adjusted 
the HRs for deprivation using the Carstairs score. Previous cardiovascular admission was 
also treated as a covariate.  Because cause of death information was judged to be reliable 
only up to 9
th
 December 2004, note that this was the end-date for all analyses of 
cardiovascular mortality.   
 
To examine differences in mortality risk associated with new-onset diabetes over follow up, 
adjusted HRs were calculated for six follow up intervals, 0-2, 2-4, 4-6, 6-8 and 10-12 years 
for both all-cause mortality and cardiovascular mortality.   
 
This study was granted ethical approval by the Tayside Committee for Medical Research 
Ethics.  
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Results 
There were 10,532 people (52.3% male) over the age of 35 years who were diagnosed with 
type 2 diabetes between 1993 and 2004; there were 21,056 non-diabetic comparators. The 
majority were matched by postal sector.  2,334 (22.2%) of the patients with diabetes had a 
previous hospital admission for cardiovascular disease, compared with 2,626 (12.5%) of the 
non-diabetic comparators. During a maximum follow-up period of 12 years, 1,863 (17.7%) 
patients with diabetes and 2,962 (14.1%) non-diabetic comparators died. The main causes of 
death were diseases of the circulatory system (44.9%, 39.3%) and neoplasms (25.3%, 
27.7%), for diabetic and non diabetic comparators respectively. Table 1 presents the numbers 
of deaths for all-cause and cardiovascular mortality by age groups for men and women 
respectively. The absolute rates per 1,000 patient years are also shown in Table 1 and Figs 1 
and 2.  
 
The higher absolute rates of all-cause mortality and cardiovascular mortality are clearly 
evident for patients with diabetes. All rates were higher for males, except the all-cause 
mortality rate among diabetic patients over 75 years. The difference in absolute rates of all-
cause mortality appeared to widen slightly among females and narrow slightly among males, 
as age increased. It is also notable that the widening of the absolute rates of cardiovascular 
mortality between diabetic patients and non-diabetic comparators appeared to occur slightly 
earlier among women than men.  
 
A Cox regression survival analysis (adjusted for deprivation) showed that patients with type 
2 diabetes had an increased HR (with 95% confidence intervals) of 1.32 (1.25 to 1.40) for 
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mortality compared with non diabetic comparators, after adjusting for differences in 
deprivation between the groups (Table 2). However, after adjusting for previous 
cardiovascular admission, the risk reduced to 1.15 (1.09 to 1.22). The risks were very similar 
for men and women. The same patterns were observed for cardiovascular mortality, although 
the HRs were slightly higher. The HRs for all-cause and cardiovascular mortality decreased 
with increasing age at diagnosis. In the age group 45-54 years, much higher HRs were 
observed among women compared to men, particularly for cardiovascular mortality.   
 
Fig 3 presents the overall HRs for all-cause and cardiovascular mortality, stratified by 
number of years follow up (duration of diabetes). Although the confidence intervals are fairly 
wide, there seems to be a trend for increasing risk of all-cause mortality with increasing 
duration of diabetes, reaching a peak between 6 and 8 years, and then decreasing. This trend 
is even more marked for cardiovascular mortality, but reaching a peak slightly earlier.  
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Conclusions 
 
This study further supports the literature showing that type 2 diabetes reduces life 
expectancy
1-4
. In general, patients with diabetes had higher absolute rates of all-cause and 
cardiovascular mortality than non-diabetic comparators, even when they were matched for 
deprivation levels (deprivation being an important confounder because deprived people are 
more likely to have diabetes
17
, and to have higher rates of mortality
18
). Even after adjusting 
more fully for deprivation and for previous cardiovascular disease, increased risks of all-
cause and cardiovascular mortality associated with type 2 diabetes were still apparent. These 
risks were much lower than those reported in cross-sectional studies
3,4
, not only because we 
adjusted for deprivation, but probably also because our longitudinal design among a clearly 
defined cohort of newly diagnosed patients, provides a more accurate estimate of risk.  
 
In general, the differences in absolute rate between diabetic patients and their comparators 
widened slightly as age at diagnosis increased. Despite this, the hazard ratios decreased with 
increasing age of diagnosis. No increased risk associated with type 2 diabetes was observed 
among very old men (over the age of 75 years), as has been observed previously
5
. This is 
also consistent with a diminishing reduction in life expectancy identified among patients with 
increasing age of diagnosis in a cross-sectional sample
19
. However, this result is slightly 
misleading in that the increased risk associated with diabetes is deemed to be low (as defined 
by the hazard ratio) when compared with a very high background mortality rate (among older 
people) and is deemed to be high when compared with a low background mortality rate 
(among younger people). While a young person diagnosed with type 2 diabetes has a very 
high HR for all-cause mortality, their absolute rate is still relatively low because the 
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background rate is low. The converse applies to older people. The HR is relatively low but 
diabetes is still associated with a large number of deaths because the background rate is high. 
It is therefore important that clinicians understand and are able to communicate measures of 
risk appropriately
20
.  
 
Similar patterns were observed for cardiovascular mortality. The risks observed were lower 
than those found in other studies
9
, perhaps because we matched and further adjusted for 
deprivation.  The effect of pre-existing cardiovascular disease on the risk of all-cause and 
cardiovascular mortality is also clearly shown, with HRs decreasing substantially after 
adjusting for this covariate, particularly for cardiovascular mortality (as might be expected). 
There were no data available for classic cardiovascular risk factors (BMI, blood pressure, 
serum lipids, smking) so it was not possible to determine to what extent this increased 
cardiovascular risk could be explained by these factors. Also, we may not have fully adjusted 
for pre-existing cardiovascular disease for those patients who had never been hospitalized. 
However, this effect is likely to be small. 
 
This study provides further evidence that diabetes confers a greater increased risk of 
cardiovascular mortality among younger women (aged 45-64 years) compared with men of 
the same age. This has been observed in other studies
21,22
, and more adverse cardiovascular 
risk profiles among women, but more aggressive treatment for men, has been one 
explanation for the difference. However, a meta-analysis found no difference between men 
and women after adjusting for cardiovascular risk factors
23
. We still found high risks of 
cardiovascular mortality among younger women even after adjusting for previous 
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cardiovascular disease (but not other cardiovascular risk factors). Nevertheless, although in 
general men have higher cardiovascular mortality rates and the actual numbers of deaths 
associated with diabetes are higher in men than women
23
, the impact of diabetes on mortality 
risk in younger women should not be under-estimated.   
 
In this study, we identified almost no adverse effect on all-cause or cardiovascular mortality 
during the first two years after diagnosis with diabetes (after adjusting for previous 
cardiovascular risk), but then a trend for increased risk with increasing duration. This 
declined after about eight years. Our results are therefore compatible with the hypothesis that 
long-term hyperglycaemia leads to atherosclerosis, and that the detrimental effects on 
mortality are not immediately evident after diagnosis, especially given that many people have 
diabetes undetected for a number of years before clinical diagnosis
24
. In contrast, a study 
from the US suggested that increased risk of all-cause and cardiovascular mortality was 
elevated immediately after diagnosis and did not appear to increase with time
9
. Note though 
that this US study was among only 282 older patients (over 65 years) and the confidence 
intervals were wide. A UK study found an increased risk of mortality during the first five 
years after diagnosis, but did not break down the risks within this period
25
. However, neither 
study adjusted for pre-existing cardiovascular disease.  
 
We are confident that the data used have produced an accurate measure of the effect of type 2 
diabetes on mortality risk. The DARTS clinical information system has high sensitivity at 
identifying patients with diabetes. Ascertainment of mortality relied on a validated national 
dataset. The underlying causes of death recorded are as stated on a patient’s death certificate, 
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so while some may have been coded incorrectly, we have probably identified most 
cardiovascular deaths. We used hospital admission as a proxy for pre-existing cardiovascular 
disease so this could have been under-estimated. However, this limitation probably applies 
equally to diabetic patients and comparators. In summary, we have provided a detailed 
analysis of all-cause and cardiovascular mortality risks among a large cohort of patients 
newly diagnosed with type 2 diabetes in Scotland.  
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Tables 
 
MALES 
All-cause mortality 
 Diabetic patients Non-diabetic comparators 
 Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI)  
Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI) 
35-44 419 (11) 5.60 (2.29-8.90) 836 (5) 1.25 (0.15-2.35) 
45-54 1052 (62) 12.84 (9.65-16.04) 2105 (61) 6.13 (4.59-7.67) 
55-64 1557 (198) 28.61 (24.62-32.59) 3118 (271) 18.87 (16.62-21.11) 
65-74 1594 (371) 56.53 (50.78-62.29) 3178 (595) 43.38 (39.90-46.87) 
75+ 884 (341) 113.68 (101.61-125.74) 1774 (646) 104.80 (96.72-112.88) 
All ages  5506 (983) 42.23 (39.59-44.87) 11,011 (1578) 32.75 (31.13-34.36) 
Cardiovascular mortality 
 Diabetic patients Non-diabetic comparators 
 Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI) 
Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI) 
35-44 411 (7) 3.69 (0.96-6.42) 821 (1) 0.26 (-0.25-0.77) 
45-54 1034 (13) 2.79 (1.27-4.30) 2063 (11) 1.15 (0.47-1.82) 
55-64 1522 (66) 9.86 (7.48-12.24) 3057 (80) 5.76 (4.50-7.02) 
65-74 1572 (141) 22.19 (18.52-25.85) 3130 (193) 14.53 (12.48-16.58) 
75+ 872 (143) 49.18 (41.12-57.24) 1750 (216) 36.16 (31.34-40.98) 
All ages 5411 (370) 16.43 (14.76-18.11) 10,821 (501) 10.75 (9.81-11.69) 
FEMALES 
All-cause mortality 
 Diabetic patients Non-diabetic comparators 
 Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI) 
Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI) 
35-44 328 (10) 6.40 (2.43-10.36) 638 (4) 1.31 (0.03-2.60) 
45-54 749 (38) 11.24 (7.67-14.82) 1512 (24) 3.36 (2.01-4.70) 
55-64 1233 (123) 20.85 (17.17-24.54) 2452 (149) 12.37 (10.38-14.35) 
65-74 1506 (255) 40.55 (35.58-45.53) 3032 (408) 30.81 (27.82-33.80) 
75+ 1210 (454) 113.92 (103.44-124.40) 2411 (799) 91.14 (84.82-97.46) 
Al ages  5026 (880) 41.68 (38.92-44.43) 10,045 (1384) 31.27 (29.63-32.92) 
Cardiovascular mortality 
 Diabetic patients Non-diabetic comparators 
 Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI) 
Total  
(no. of deaths)  
Absolute rate  
per 1,000 pat yrs  
(95% CI) 
35-44 321 (2) 1.32 (-0.51-3.16) 624(1) 0.34 (-0.33-1.01) 
45-54 733 (9) 2.76 (0.96-4.56) 1482 (3) 0.43 (-0.06-0.93) 
55-64 1215 (42) 7.35 (5.13-9.58) 2414(27) 2.32 (1.44-3.19) 
65-74 1485 (97) 15.96 (12.79-19.14) 2989 (125) 9.77 (8.05-11.48) 
75+ 1182 (165) 42.76 (36.24-49.29) 2356 (297) 34.96 (30.98-38.93) 
All ages 4936 (315) 15.43 (13.72-17.13) 9865 (453) 10.59 (9.61-11.56) 
 
Table 1: Total numbers of deaths and absolute rates of mortality and cardiovascular 
mortality (with 95% CI) for patients with type 2 diabetes and non diabetic 
comparators, stratified by age and sex  
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 All-cause mortality Cardiovascular mortality 
 HR (95% CI) – 
adjusted for 
deprivation only 
HR (95% CI) – adjusted 
for deprivation and 
previous cardiovascular 
disease 
HR (95% CI) – adjusted 
for deprivation only 
HR (95% CI) – adjusted 
for deprivation and 
previous cardiovascular 
disease 
Men 
35-44 4.59 (1.59-13.28) 4.17 (1.41-12.35) 15.91 (1.94-130.16) 14.74 (1.77-122.69) 
45-54 2.19 (1.53-3.13) 2.01 (1.39-2.91) 2.44 (1.09-5.46) 1.95 (0.84-4.52) 
55-64 1.52 (1.27-1.83) 1.36 (1.13-1.64) 1.73 (1.25-2.40) 1.33 (0.95-1.86) 
65-74 1.33 (1.17-1.52) 1.22 (1.07-1.39) 1.57 (1.26-1.95) 1.36 (1.09-1.70) 
75+ 1.11 (0.97-1.26) 1.06 (0.92-1.20) 1.40 (1.14-1.74) 1.29 (1.04-1.60) 
All Ages (35+) 1.30 (1.20-1.41) 1.14 (1.05-1.24) 1.55 (1.36-1.78) 1.26 (1.10-1.45) 
Women     
35-44 4.38 (1.36-14.08) 3.90 (1.20-12.65) 3.59 (0.32-40.71) 2.15 (0.16-28.12) 
45-54 3.20 (1.90-5.36) 2.67 (1.57-4.56) 6.43 (1.73-23.87) 4.97 (1.29-19.15) 
55-64 1.69 (1.32-2.14) 1.51 (1.18-1.93) 3.16 (1.94-5.13) 2.71 (1.65-4.46) 
65-74 1.32 (1.13-1.54) 1.17 (1.00-1.37) 1.63 (1.25-2.13) 1.34 (1.02-1.76) 
75+ 1.29 (1.15-1.45) 1.20 (1.07-1.35) 1.26 (1.04-1.52) 1.13 (0.93-1.37) 
All Ages (35+) 1.34 (1.23-1.46) 1.16 (1.07-1.27) 1.47 (1.27-1.69) 1.19 (1.03-1.38) 
All     
35-44 4.46 (2.03-9.78) 3.98 (1.79-8.86) 9.32 (2.00-43.54) 7.92 (1.65-37.91) 
45-54 2.52 (1.89-3.38) 2.26 (1.68-3.05) 3.31 (1.69-6.47) 2.62 (1.31-5.27) 
55-64 1.57 (1.36-1.82) 1.39 (1.20-1.62) 2.09 (1.60-2.74) 1.64 (1.25-2.17) 
65-74 1.32 (1.20-1.46) 1.19 (1.08-1.32) 1.59 (1.34-1.88) 1.35 (1.13-1.60) 
75+ 1.21 (1.11-1.32) 1.13 (1.04-1.24) 1.32 (1.15-1.52) 1.20 (1.04-1.38) 
All Ages (35+) 1.32 (1.25-1.40) 1.15 (1.09-1.22) 1.51 (1.37-1.67) 1.23 (1.11-1.36) 
 
Table 2: Hazard ratios for risks of mortality and cardiovascular mortality among 
patients with type 2 diabetes compared to non-diabetic comparators, stratified by age 
and sex.  
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Fig 2 
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Fig 3  
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Legend to Figures 
 
Figure 1: Absolute rates of all-cause mortality among newly diagnosed patients with type 2 
diabetes and non-diabetic comparators.  
Figure 2: Absolute rates of cardiovascular mortality among newly diagnosed patients with 
type 2 diabetes and non-diabetic comparators.  
Figure 3: Hazard ratios, adjusted for deprivation and previous cardiovascular admission, for 
all-cause and cardiovascular mortality among patients with diabetes compared to non-
diabetic comparators, stratified by length of follow-up (duration of diabetes).  
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